AstraZeneca boasts a remarkably healthy drug portfolio and a pipeline of promising drugs in clinical development. Read why ...

Feb 28 (Reuters) - The European Union's health regulator on Friday backed AstraZeneca (AZN.L), opens new tab and Daiichi Sankyo's (4568.T), opens new tab drug Enhertu as a breast cancer treatment ...

As Ioana Crisan, Chief Financial Officer of AstraZeneca Switzerland, emphasises, the entire sales force is also travelling electrically: “Knowing that the switch to electric cars poses challenges, we ...

AstraZeneca said its breast cancer drug candidate showed positive results in a late stage trial, with improved progression-free survival in patients. The British pharma giant said Wednesday that ...

As anyone who’s watched The Sixth Sense will know, a good twist is pretty exciting. And the Cupra Leon we're reviewing here is a fast car with its own interesting twist – and not just because ...

As anyone who’s watched The Sixth Sense will know, a good twist is pretty exciting. And the Cupra Leon we're reviewing here is a fast car with its own interesting twist – and not just because ...

On October 30, 2024, AstraZeneca announced that Leon Wang, Executive Vice President International and AstraZeneca China President, was "cooperating wth an ongoing investigation by Chinese authorities.

Ceremonia del Premio Pritzker 2017: Ryue Nishizawa (izquierda), Tadao Ando, Kazuyo Sejima, Rafael Aranda, Glenn Murcutt, Carme Pigem, Ramon Vilalta, Toyo Ito, Shigeru ...

In December, AstraZeneca appointed Iskra Reic as its new international executive vice president, replacing Leon Wang, who has been detained by authorities in China. They are investigating some ...

FibroGen sells its China unit to AstraZeneca for about $160M, strengthening its cash position and extending its financial runway into 2027. AstraZeneca gains full rights to roxadustat in China ...

AstraZeneca is paying $160 million for FibroGen ... as authorities investigate the company’s former China head Leon Wang. In a fourth-quarter earnings call earlier this month, AstraZeneca ...